"pancreatic cancer" trang 10 - tải miễn phí từ tailieunhanh
Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer

Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer
7    1    1
Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer

Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer
14    1    1
Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: Results from the national mortality surveillance system

Mortality and years of life lost due to pancreatic cancer in China, its provinces, urban and rural areas from 2005 to 2020: Results from the national mortality surveillance system
9    1    1
Time trend of pancreatic cancer mortality in the Western Pacifc Region: Age-period-cohort analysis from 1990 to 2019 and forecasting for 2044

Time trend of pancreatic cancer mortality in the Western Pacifc Region: Age-period-cohort analysis from 1990 to 2019 and forecasting for 2044
13    1    1
MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway

MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway
12    4    1
Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin

Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin
8    4    1
Immune landscape and prognostic index for pancreatic cancer based on TCGA database and in vivo validation

Immune landscape and prognostic index for pancreatic cancer based on TCGA database and in vivo validation
11    1    1
Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer

Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer
10    4    1
Establishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer

Establishment and validation of a nomogram based on coagulation parameters to predict the prognosis of pancreatic cancer
10    6    1
Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer

Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer
21    6    1
A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)

A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)
10    8    1
S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: A bioinformatics analysis and in vitro study

S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: A bioinformatics analysis and in vitro study
14    8    1
Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PDL1 and CXCR4

Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PDL1 and CXCR4
12    1    1
Initial treatment is associated with improved survival and end-of-life outcomes for patients with pancreatic cancer: A cohort study

Initial treatment is associated with improved survival and end-of-life outcomes for patients with pancreatic cancer: A cohort study
9    1    1
Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer

Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer
16    2    1
Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgery

Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgery
11    4    1
Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer

Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer
24    1    1
Modified geriatric nutritional risk index in patients with pancreatic cancer: A propensity score-matched analysis

Modified geriatric nutritional risk index in patients with pancreatic cancer: A propensity score-matched analysis
8    1    1
Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: A retrospective study

Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: A retrospective study
9    1    1
Causal effect between gut microbiota and pancreatic cancer: A two-sample Mendelian randomization study

Causal effect between gut microbiota and pancreatic cancer: A two-sample Mendelian randomization study
10    3    1